LBB Specialties expands its Clariant partnership to supply pharmaceutical-grade excipients and technical support in Puerto Rico’s Life Sciences market.
LBB Specialties (LBBS), a prominent distributor of specialty chemicals and ingredients across North America, has announced the significant expansion of its distribution alliance with Clariant, a globally recognized manufacturer and innovator in specialty chemical solutions. This strategic move is set to bolster LBBS’s footprint in Puerto Rico's dynamic and growing Life Sciences sector, a key hub for pharmaceutical manufacturing.
Through this extended partnership, LBBS will now provide the Puerto Rican market with Clariant’s comprehensive range of pharmaceutical-grade excipients, notably including the well-regarded VitiPure™ product line. These excipients are produced in adherence to strict Good Manufacturing Practices (GMP) and are tailored to meet the rigorous standards of pharmaceutical and biopharmaceutical industries, with special focus on low endotoxin levels and stringent microbial control.
A central component of this agreement is LBBS’s commitment to maintaining locally stocked inventory and offering robust technical and commercial support directly within Puerto Rico. This move ensures greater accessibility and responsiveness for local pharmaceutical manufacturers, reducing supply chain complexity and enhancing operational efficiency.
Seth Burns, Senior Vice President of Life Sciences at LBB Specialties, emphasized the strategic importance of the Puerto Rican market, stating, “Puerto Rico remains a top destination for pharmaceutical companies setting up FDA-approved manufacturing operations. Our expanded partnership with Clariant underscores our dedication to supporting the region’s Life Sciences community by providing world-class excipients and dependable local services. We aim to facilitate formulation innovation while ensuring technical reliability and supply chain continuity.”
Echoing this sentiment, Vaios Barlas, Head of Health Care at Clariant, highlighted the collaborative value of the extended relationship. “Our expanded collaboration with LBBS is a strategic step towards reinforcing our international presence. The local availability of our complete excipient portfolio meets a critical need in this vital market. LBBS’s long-standing expertise and established infrastructure in Puerto Rico align seamlessly with Clariant’s mission to deliver the highest quality pharmaceutical-grade ingredients that meet stringent regulatory and performance requirements.”
The partnership is poised to support Puerto Rico's thriving pharmaceutical landscape, which is home to numerous FDA-approved production facilities and continues to attract investment due to its skilled workforce and favorable regulatory environment. With LBBS now acting as a conduit for Clariant’s high-purity excipient portfolio on the island, pharmaceutical and biopharmaceutical manufacturers can expect enhanced supply reliability, local engagement, and customized technical support.
This development marks a milestone for both companies as they deepen their collaboration to serve the specialized needs of the Life Sciences industry, reinforcing a shared vision focused on innovation, compliance, and customer-centric service delivery.
Clariant provides a comprehensive portfolio of pharmaceutical-grade excipients, featuring well-known brands such as VitiPure®, Polyglykol®, Lanogen®, and Motusflex®. The company also offers ultra-purified variants like VitiPure O 80 Superior (Polysorbate 80) and VitiPure CO 35 Superior (Polyoxyl 35 Castor Oil), specifically designed for applications demanding minimal microbial contamination and exceptional purity.
